These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 34717646)

  • 1. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
    Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
    J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
    Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
    J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
    Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
    ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy.
    Hou C; Ma N; Shen Z; Chi G; Chao S; Pei Y; Chen L; Lu Y; Pei Z
    Int J Nanomedicine; 2020; 15():10417-10424. PubMed ID: 33376329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
    He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
    Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
    Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
    Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
    [No Abstract]   [Full Text] [Related]  

  • 11. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
    Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
    Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
    Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
    Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Microenvironment-Activatable Nanoreactor Based on a Polyprodrug for Multimodal-Imaging-Medicated Enhanced Cancer Chemo/Phototherapy.
    Shi X; Ma X; Ren E; Zhang Y; Jia D; Gao Y; Xue P; Kang Y; Liu G; Xu Z
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):40704-40715. PubMed ID: 31577408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor-targeted theranostic IrS
    Zhang DY; Zheng Y; Zhang H; Yang GG; Tan CP; He L; Ji LN; Mao ZW
    Nanoscale; 2018 Dec; 10(47):22252-22262. PubMed ID: 30465053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
    Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
    Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
    Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B
    Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
    Li Y; Lu H; Liang S; Xu S
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.